Get started
Author

Emanuele Canestrari

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
2009 · F Loupakis, A Ruzzo, et al. · British Journal of Cancer · 574
PDF
PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer
2009 · Fotios Loupakis, Luca Pollina, et al. · Journal of Clinical Oncology · 412
Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy
2007 · Annamaria Ruzzo, Francesco Graziano, et al. · Journal of Clinical Oncology · 272
PDF
High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice
2008 · Daniele Santini, Fotios Loupakis, et al. · The Oncologist · 240
PDF
Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer
2011 · Francesco Graziano, Nadia Galluccio, et al. · Journal of Clinical Oncology · 166
Pharmacogenetic Profiling for Cetuximab Plus Irinotecan Therapy in Patients With Refractory Advanced Colorectal Cancer
2008 · Francesco Graziano, Annamaria Ruzzo, et al. · Journal of Clinical Oncology · 135
Pharmacogenetic Profiling and Clinical Outcome of Patients With Advanced Gastric Cancer Treated With Palliative Chemotherapy
2006 · Annamaria Ruzzo, Francesco Graziano, et al. · Journal of Clinical Oncology · 133
PDF
Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab–irinotecan
2010 · F Graziano, E Canestrari, et al. · The Pharmacogenomics Journal · 120
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
2007 · A Ruzzo, F Graziano, et al. · The Pharmacogenomics Journal · 100
High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease
2012 · Annamaria Ruzzo, Francesco Graziano, et al. · The Oncologist · 76
PDF
Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer
2011 · Fotios Loupakis, Annamaria Ruzzo, et al. · BMC Cancer · 74
PDF
Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype
2005 · A. Ruzzo, F. Graziano, et al. · Annals of Oncology · 71
PDF
PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres
2014 · I Kastrati, E Canestrari, et al. · Oncogene · 61
Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer
2007 · Annamaria Ruzzo, Emanuele Canestrari, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 61
VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population
2008 · Paolo Maltese, Emanuele Canestrari, et al. · International Journal of Colorectal Disease · 55
Rescuing dicer Defects via Inhibition of an Anti-Dicing Nuclease
2014 · Ken Asada, Emanuele Canestrari, et al. · Cell Reports · 50
PDF
High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice
2010 · D. Santini, C. Spoto, et al. · Annals of Oncology · 46
PDF
Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity
2019 · Alejandro Torres Chavez, Mary Kathryn McKenna, et al. · Journal for ImmunoTherapy of Cancer · 45
PDF
Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients
2010 · A. Ruzzo, F. Graziano, et al. · Current Cancer Drug Targets · 42
Human Platelet Lysate Media Supplement Supports Lentiviral Transduction and Expansion of Human T Lymphocytes While Maintaining Memory Phenotype
2019 · Emanuele Canestrari, Hayley R. Steidinger, et al. · Journal of Immunology Research · 36
PDF
Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy
2014 · Annamaria Ruzzo, Vincenzo Catalano, et al. · BMC Cancer · 31
PDF
Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: Clinical outcome according to KRAS and BRAF mutational status
2010 · Lorenzo Fornaro, Giacomo Giulio Baldi, et al. · Critical Reviews in Oncology/Hematology · 31
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer
2008 · F Graziano, A Ruzzo, et al. · The Pharmacogenomics Journal · 31
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
2008 · F Graziano, A Ruzzo, et al. · British Journal of Cancer · 31
PDF
High resolution melting (HRM) analysis for the detection of ER22/23EK, BclI, and N363S polymorphisms of the glucocorticoid receptor gene
2009 · Paolo Maltese, Emanuele Canestrari, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 26
Works count: 56
Citation count: 3,037
H-index: 25
I10-index: 29
Year
Topic
Type